| Breast Cancer |
1 |
1 |
| Antineoplastic Drug |
0 |
0.75 |
| Biologic Therapy |
0 |
0.6 |
| Advanced and Metastatic Breast Cancer |
0 |
0.8 |
| Humanized Monoclonal Antibody |
0 |
0.78 |
| HER2-Positive Breast Cancer |
0 |
0.99 |
| Breast |
0 |
0.42 |
| Toxicology |
0 |
0.38 |
| Cancer |
0 |
0.36 |
| Head and Neck Cancer |
0 |
0.3 |
| Metastasis |
0 |
0.28 |
| Cornea and External Disease |
0 |
0.17 |
| Interstitial Lung Disease |
0 |
0.14 |
| Antibody Drug Conjugates |
0 |
0.13 |
| Conjunctivitis |
0 |
0.13 |
| Hodgkin Lymphoma |
0 |
0.13 |
| Lung |
0 |
0.13 |
| Keratitis |
0 |
0.1 |
| Orbit |
0 |
0.1 |
| Skin and Soft Tissue Infection |
0 |
0.1 |
| Brain Metastasis |
0 |
0.09 |
| Fatigue |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Tumor |
0 |
0.07 |
| CT Scan |
0 |
0.06 |
| Brain |
0 |
0.03 |
| Diarrhea |
0 |
0.03 |
| Europe |
0 |
0.03 |
| Massachusetts |
0 |
0.03 |
| Nausea |
0 |
0.03 |
| New York |
0 |
0.03 |
| Quality of Life |
0 |
0.03 |
| Scan |
0 |
0.03 |